Media coverage
5
Media coverage
Title ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas Media name/outlet Business Wire Country/Territory United States Date 6/05/25 URL ct.moreover.com/?a=56668683833&p=1gw&v=1&x=qajHoPai06PZkGEM8ebFAg Persons Stephen Badylak Title ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas; FDA allowing this technology to move forward to clinical investigation marks key milestone for regenerative hydrogel platform in treating Media name/outlet Business Wire Country/Territory United States Date 6/05/25 Persons Stephen Badylak Title ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas Media name/outlet APNews.com Country/Territory United States Date 6/05/25 URL ct.moreover.com/?a=56668624046&p=1gw&v=1&x=uZh1Yv8lhV0igIqdeXL_bg Persons Stephen Badylak Title ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas Media name/outlet Yahoo! Finance Country/Territory United States Date 6/05/25 URL ct.moreover.com/?a=56668730349&p=1gw&v=1&x=cIdsL3EAWE368opIXgOR1Q Persons Stephen Badylak Title ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas Media name/outlet Le Lezard.com Country/Territory Canada Date 6/05/25 URL ct.moreover.com/?a=56668661295&p=1gw&v=1&x=8LZIl1oKDkAOndqrauUETA Persons Stephen Badylak